tiprankstipranks
Trending News
More News >
Central Garden & Pet (CENT)
:CENT
Advertisement

Central Garden Pet (CENT) AI Stock Analysis

Compare
198 Followers

Top Page

CENT

Central Garden Pet

(NASDAQ:CENT)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 4o)
Rating:73Outperform
Price Target:
$37.00
▲(19.97% Upside)
Central Garden Pet's strong financial performance and strategic focus on high-margin products are significant strengths. The technical analysis suggests short-term bullish momentum, while the valuation is reasonable. The earnings call provided a mixed outlook, with record performance but some challenges. Overall, the stock demonstrates solid potential with areas for cautious optimism.
Positive Factors
Gross Margin Expansion
The expansion in gross margin reflects improved cost efficiency and productivity, enhancing long-term profitability and competitive positioning.
Strategic Focus on High-Margin Products
Focusing on high-margin products strengthens the company's portfolio, driving sustainable profit growth and market differentiation.
Financial Flexibility
The new credit facility enhances liquidity and operational capacity, supporting strategic investments and growth initiatives.
Negative Factors
Net Sales Decline
A decline in net sales indicates potential challenges in market demand and competitive pressures, impacting revenue growth.
Tariff Challenges
Tariff exposure can increase costs and reduce margins, posing long-term risks to profitability and market competitiveness.
Decline in Pet Segment Sales
A significant decline in the Pet segment sales suggests challenges in product demand or market competition, affecting overall revenue.

Central Garden Pet (CENT) vs. SPDR S&P 500 ETF (SPY)

Central Garden Pet Business Overview & Revenue Model

Company DescriptionCentral Garden & Pet Company (CENT) is a leading provider of pet and garden products in the United States. The company operates through two main segments: the Pet segment, which includes products such as pet food, treats, and supplies for both companion animals and aquatics, and the Garden segment, which offers a wide range of products, including lawn and garden care items, fertilizers, and pest control solutions. With a diverse portfolio of brands and a strong distribution network, Central Garden & Pet aims to enhance the lives of pets and the beauty of gardens.
How the Company Makes MoneyCentral Garden & Pet generates revenue primarily through the sale of its pet and garden products across various retail channels, including mass merchants, specialty pet stores, and home improvement retailers. The company employs a multi-faceted revenue model that encompasses direct sales to retailers, e-commerce sales, and distribution agreements. Key revenue streams include the sale of branded products, private label offerings, and specialty items that cater to specific pet and gardening needs. Additionally, partnerships with major retailers and online platforms significantly enhance its market reach and sales potential. Seasonal demand for gardening products also plays a crucial role in revenue fluctuations, while ongoing innovation and introduction of new products help drive sales growth.

Central Garden Pet Earnings Call Summary

Earnings Call Date:Nov 24, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Feb 11, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mixed outlook. While the company achieved record financial performance and demonstrated operational efficiency, challenges such as declining net sales, tariff impacts, and increased corporate expenses were evident. The strategic focus on high-margin products and a positive outlook for the Garden segment provide reasons for cautious optimism.
Q4-2025 Updates
Positive Updates
Record Financial Performance
Central Garden & Pet Company achieved record EBITDA and earnings per share for fiscal year 2025, demonstrating robust financial health and successful execution of strategic initiatives.
Gross Margin Expansion
The company reported a 210 basis points increase in non-GAAP gross margin to 32.1%, supported by productivity initiatives across both segments.
Operational Efficiency
Completion of a multiyear supply chain network design project and the consolidation of facilities contributed to enhanced customer alignment and cost efficiency.
Strategic Focus on High-Margin Products
Shifted focus to high-margin consumable products, with consumables now representing 84% of Pet segment sales, contributing to a stronger portfolio.
Positive Garden Segment Performance
The Garden segment saw a 7% increase in net sales in Q4, driven by strong product placements and favorable weather conditions.
Negative Updates
Net Sales Decline
Net sales for fiscal year 2025 decreased by 2%, primarily due to strategic decisions to reduce exposure to lower-margin businesses and challenges in the UK market.
Tariff Challenges
The company faced gross tariff exposure of approximately $20 million, impacting the Pet segment significantly.
Durables Segment Decline
The Pet segment experienced a 22% decrease in net sales in Q4 due to lower durable sales and closure of UK operations.
Corporate Expense Increase
Corporate expenses increased by $11 million in Q4, driven by timing variations, investments for future growth, and miscellaneous true-ups.
Company Guidance
During the earnings call for Central Garden & Pet Company's fourth quarter and fiscal year 2025, several key metrics and strategic initiatives were highlighted. The company reported a record bottom-line performance, with net sales reaching $3.1 billion, despite a 2% decrease attributed to strategic reductions in lower-margin businesses and the transition of certain product lines to a direct-to-retail model. Gross profit increased by 4.5% to $1 billion, and gross margin expanded by 210 basis points to 32.1%, driven by productivity initiatives. The Garden segment showed a 7% increase in net sales to $250 million, while the Pet segment experienced a 22% decrease to $428 million. Non-GAAP operating income rose to $265 million, with an operating margin of 8.5%, up from 7% the previous year. The company ended the year with a strong balance sheet, including cash and cash equivalents of $882 million and a net leverage of approximately 0.8. Looking ahead, Central Garden & Pet expects non-GAAP earnings per share for fiscal 2026 to be $2.70 or better, supported by margin expansion and operational performance. The company plans to invest $50 million to $60 million in capital expenditures, primarily for maintenance and productivity initiatives, and is focused on driving growth through innovation, e-commerce, and digital technology.

Central Garden Pet Financial Statement Overview

Summary
Central Garden Pet exhibits strong financial health with impressive revenue and profit growth, improved margins, and a stable balance sheet. The company effectively manages its debt levels, though the high leverage requires careful monitoring. Cash flow performance is generally solid, but recent declines in free cash flow growth suggest areas for improvement.
Income Statement
78
Positive
Central Garden Pet's income statement shows a strong performance with a notable improvement in gross profit margin to 31.87% in TTM, up from 29.49% in the previous year. The net profit margin also increased to 5.20% from 3.37%, indicating enhanced profitability. Revenue growth rate for TTM is robust at 27.8%, recovering from a decline in the previous year. EBIT and EBITDA margins have improved, reflecting efficient cost management. Overall, the income statement demonstrates solid growth and profitability, though past fluctuations in revenue growth suggest potential volatility.
Balance Sheet
72
Positive
The balance sheet indicates a stable financial position with a debt-to-equity ratio of 0.91 in TTM, showing a slight improvement from previous years, suggesting effective debt management. Return on equity (ROE) has increased to 10.45%, indicating better utilization of equity to generate profits. The equity ratio remains stable, reflecting a balanced capital structure. However, the company has maintained a relatively high level of debt, which could pose risks if not managed carefully.
Cash Flow
65
Positive
Cash flow analysis reveals a mixed performance. The operating cash flow to net income ratio is 0.65 in TTM, indicating moderate cash generation relative to net income. Free cash flow to net income ratio is strong at 0.88, suggesting efficient cash conversion. However, free cash flow growth has declined by 6.78% in TTM, highlighting potential challenges in cash flow management. While the company maintains healthy cash flow ratios, the recent decline in free cash flow growth warrants attention.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.13B3.20B3.31B3.34B3.30B2.70B
Gross Profit997.34M943.74M946.84M992.30M970.90M796.56M
EBITDA325.02M290.76M307.17M340.98M329.22M253.34M
Net Income162.84M107.98M125.64M152.15M151.75M120.68M
Balance Sheet
Total Assets3.56B3.55B3.38B3.28B3.12B2.34B
Cash, Cash Equivalents and Short-Term Investments882.49M753.55M488.73M177.44M426.42M652.71M
Total Debt1.44B1.42B1.37B1.38B1.36B814.06M
Total Liabilities1.98B2.00B1.93B1.95B1.89B1.26B
Stockholders Equity1.58B1.56B1.45B1.33B1.22B1.08B
Cash Flow
Free Cash Flow291.09M351.76M327.67M-149.24M170.51M221.22M
Operating Cash Flow332.51M394.89M381.63M-34.03M250.84M264.27M
Investing Cash Flow-44.89M-105.19M-34.58M-142.98M-899.36M-48.11M
Financing Cash Flow-156.64M-25.44M-37.55M-66.81M420.48M-60.56M

Central Garden Pet Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price30.84
Price Trends
50DMA
31.65
Positive
100DMA
34.32
Negative
200DMA
35.03
Negative
Market Momentum
MACD
0.59
Negative
RSI
58.69
Neutral
STOCH
57.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CENT, the sentiment is Neutral. The current price of 30.84 is below the 20-day moving average (MA) of 32.39, below the 50-day MA of 31.65, and below the 200-day MA of 35.03, indicating a neutral trend. The MACD of 0.59 indicates Negative momentum. The RSI at 58.69 is Neutral, neither overbought nor oversold. The STOCH value of 57.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CENT.

Central Garden Pet Risk Analysis

Central Garden Pet disclosed 33 risk factors in its most recent earnings report. Central Garden Pet reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Central Garden Pet Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$1.83B14.3210.38%-2.23%57.00%
69
Neutral
$1.26B3.90-0.78%265.56%
69
Neutral
$1.76B27.116.82%3.45%0.54%-24.42%
67
Neutral
$3.03B27.1711.22%16.34%177.51%
63
Neutral
$1.89B18.605.86%8.98%-26.29%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
57
Neutral
-4.30%-70.31%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CENT
Central Garden Pet
33.52
-7.50
-18.28%
HLF
Herbalife
12.20
4.27
53.85%
JJSF
J & J Snack Foods
90.97
-75.42
-45.33%
SMPL
Simply Good Foods
18.93
-20.95
-52.53%
FRPT
Freshpet
62.05
-87.66
-58.55%
KLG
WK Kellogg Co
23.00
2.84
14.09%

Central Garden Pet Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Central Garden Pet Secures $600M Credit Facility
Positive
Nov 12, 2025

On November 7, 2025, Central Garden & Pet Company entered into a Fourth Amended and Restated Credit Agreement, establishing a $600 million senior secured asset-based revolving credit facility with the potential to increase by $400 million. This agreement, which matures in 2030, provides the company with financial flexibility for general corporate purposes and includes various borrowing options and interest rate structures. The facility is secured by the company’s assets and includes covenants and financial requirements, reflecting a strategic move to enhance liquidity and operational capacity.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025